Records and reported status
Aug 13, 2026 FDA drug enforcement
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by... Apr 8, 2026 FDA drug enforcement
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Class II Reported ongoing
Distribution: U.S.A. Nationwide
Official source for Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc... Mar 5, 2026 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported ongoing
Distribution: U.S. Nationwide
Official source for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apot... Sep 5, 2025 FDA drug enforcement
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Class II Reported ongoing
Distribution: Nationwide in the US
Official source for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Onl... Sep 5, 2025 FDA drug enforcement
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Class II Reported ongoing
Distribution: Nationwide in the US
Official source for Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex... May 28, 2025 FDA drug enforcement
Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, ... May 28, 2025 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., T... May 28, 2025 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by: Apotex Inc., Tor... May 28, 2025 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported ongoing
Distribution: US Nationwide.
Official source for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Man... Feb 9, 2024 FDA drug enforcement
CGMP Deviations: potential presence of Burkholderia cepacia complex
Class II Reported ongoing
Distribution: Nationwide in the USA
Official source for Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufa... Nov 1, 2023 FDA drug enforcement
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class II Reported ongoing
Distribution: Nationwide
Official source for Paroxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 1... Nov 1, 2023 FDA drug enforcement
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class II Reported ongoing
Distribution: Nationwide
Official source for Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle, NDC#:60505-0083-2; b) ... Nov 1, 2023 FDA drug enforcement
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class II Reported ongoing
Distribution: Nationwide
Official source for Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)10... Nov 1, 2023 FDA drug enforcement
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
Class II Reported ongoing
Distribution: Nationwide
Official source for Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufa... Apr 26, 2023 FDA drug enforcement
Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.
Class II Reported completed
Distribution: Nationwide throughout the United States
Official source for Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Ca... Mar 1, 2023 FDA drug enforcement
Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
Class II Reported completed
Distribution: Nationwide in the USA
Official source for Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC... Dec 21, 2022 FDA drug enforcement
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Class III Reported terminated
Distribution: USA Nationwide
Official source for Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Onta... Jul 7, 2022 FDA drug enforcement
Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Class II Reported terminated
Distribution: USA Nationwide
Official source for Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505... May 3, 2022 FDA drug enforcement
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
Class III Reported terminated
Distribution: Nationwide in the USA
Official source for Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, On...
Reasons in these listed records Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. Lack of Assurance of Sterility Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns These examples come from this result page and are not a ranking of every recall reason.
Checking Apotex Corp. Is there a recall on apotex corp. right now? This archive contains 19 records, including 14 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Where can I find older records? Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.